BC
RCKT icon

Boxer Capital’s Rocket Pharmaceuticals RCKT Stock Holding History

Boxer Capital’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,466,051
Closed -$27.1M – 42
2024
Q3 		$27.1M Hold
1,466,051
– – 1.33% 21
2024
Q2 		$31.6M Hold
1,466,051
– – 1.66% 19
2024
Q1 		$39.5M Hold
1,466,051
– – 1.95% 16
2023
Q4 		$43.9M Hold
1,466,051
– – 2.19% 16
2023
Q3 		$30M Hold
1,466,051
– – 1.6% 21
2023
Q2 		$29.1M Hold
1,466,051
– – 1.35% 25
2023
Q1 		$25.1M Hold
1,466,051
– – 1.23% 27
2022
Q4 		$28.7M Hold
1,466,051
– – 1.51% 23
2022
Q3 		$23.4M Hold
1,466,051
– – 1.32% 28
2022
Q2 		$20.2M Hold
1,466,051
– – 1.28% 29
2022
Q1 		$23.3M Hold
1,466,051
– – 1.2% 24
2021
Q4 		$32M Hold
1,466,051
– – 1.24% 22
2021
Q3 		$43.8M Hold
1,466,051
– – 1.53% 15
2021
Q2 		$64.9M Hold
1,466,051
– – 2.29% 7
2021
Q1 		$65M Hold
1,466,051
– – 2.21% 9
2020
Q4 		$80.4M Hold
1,466,051
– – 2.58% 9
2020
Q3 		$33.5M Hold
1,466,051
– – 1.16% 21
2020
Q2 		$30.7M Hold
1,466,051
– – 1.35% 29
2020
Q1 		$20.5M Hold
1,466,051
– – 1.39% 23
2019
Q4 		$33.4M Hold
1,466,051
– – 1.89% 14
2019
Q3 		$17.1M Hold
1,466,051
– – 1.24% 23
2019
Q2 		$22M Hold
1,466,051
– – 1.89% 17
2019
Q1 		$25.7M Sell
1,466,051
-500,000
-25% -$7.89M 2.97% 14
2018
Q4 		$29.1M Hold
1,966,051
– – 3.6% 10
2018
Q3 		$48.4M Hold
1,966,051
– – 5.37% 8
2018
Q2 		$38.6M Hold
1,966,051
– – 4.37% 10
2018
Q1 		$36.9M Buy
1,966,051
+1,716,051
+686% +$28M 3.93% 11
2017
Q4 		$2.61M Buy
+250,000
New +$2.48M 0.48% 23

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital's RCKT Position: Q4 2024 in Review

Boxer Capital sold out of Rocket Pharmaceuticals (RCKT) in Q4 2024, closing a stake of 1,466,051 shares — an estimated $27.1M sold.

Boxer Capital first reported a position in RCKT in Q4 2017 and held it in 28 quarters. The position peaked at $80.4M in Q4 2020. 225 funds tracked by Wall St. Rank hold RCKT as of Q4 2024.

  • Boxer Capital reported no remaining Rocket Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Boxer Capital sold 1,466,051 Rocket Pharmaceuticals shares in Q4 2024, an estimated $27.1M.
  • Boxer Capital first reported a position in Rocket Pharmaceuticals in Q4 2017 and held it in 28 quarters.
  • Boxer Capital's Rocket Pharmaceuticals position peaked at $80.4M in Q4 2020.
  • 225 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.